Cancer: Combating resistance to EGFR inhibitors

被引：5
|
作者：
Crunkhorn S.
机构：
来源：
Nature Reviews Drug Discovery | 2019年 / 18卷 / 1期
关键词：
D O I：
10.1038/nrd.2018.232
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：18 / 18
相关论文
共 50 条
  • [31] Signaling mechanisms of resistance to EGFR- and Anti-Angiogenic Inhibitors cancer
    Mirone, Giovanna
    Shukla, Arvind
    Marfe, Gabriella
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 85 - 95
  • [32] Overcoming Resistance to Anti-EGFR Therapy in Breast Cancer with Rac Inhibitors
    Borrero-Garcia, Luis Daniel
    Troche-Torres, Angel Luis
    Maldonado, Maria del Mar
    Dharmawardhane, Suranganie
    FASEB JOURNAL, 2017, 31
  • [33] Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells
    Liu, Bi-Sheng
    Xia, Hong-Wei
    Zhou, Sheng
    Liu, Qing
    Tang, Qiu-Lin
    Bi, Na-Xi
    Zhou, Ji-Tao
    Gong, Qi-Yong
    Nie, Yong-Zhan
    Bi, Feng
    ONCOLOGY REPORTS, 2018, 40 (04) : 2171 - 2182
  • [34] Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
    Stefanski, Casey D.
    Prosperi, Jenifer R.
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 229 - 232
  • [35] Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer
    Park, Silvia
    Langley, Emma
    Sun, Jong-Mu
    Lockton, Steve
    Ahn, Jin Seok
    Jain, Anjali
    Park, Keunchil
    Singh, Sharat
    Kim, Phillip
    Ahn, Myung-Ju
    ONCOTARGET, 2015, 6 (31) : 30929 - 30938
  • [36] The Effect of Acquired Cisplatin Resistance on Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells
    Rho, Jin Kyung
    Choi, Yun Jung
    Choi, You Ri
    Kim, Sun Ye
    Choi, Su Jin
    Choi, Chang-Min
    Na, Im Il
    Lee, Jae Cheol
    ONCOLOGY RESEARCH, 2011, 19 (10-11) : 471 - 478
  • [37] Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
    Lu Yang
    Arup Bhattacharya
    Yun Li
    Sandra Sexton
    Xiang Ling
    Fengzhi Li
    Yuesheng Zhang
    Journal of Experimental & Clinical Cancer Research, 41
  • [38] Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
    Yang, Lu
    Bhattacharya, Arup
    Li, Yun
    Sexton, Sandra
    Ling, Xiang
    Li, Fengzhi
    Zhang, Yuesheng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [39] Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
    Park, Siyeon
    Park, Seongyeol
    Kim, Tae Min
    Kim, Soyeon
    Koh, Jaemoon
    Lim, Joonoh
    Yi, Kijong
    Yi, Boram
    Ju, Young Seok
    Kim, Miso
    Keam, Bhumsuk
    Kim, Jung Sun
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Kim, Young Tae
    Heo, Dae Seog
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [40] Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review
    Mansour, Mostafa A.
    AboulMagd, Asmaa M.
    Abbas, Samar H.
    Abdel-Rahman, Hamdy M.
    Abdel-Aziz, Mohamed
    RSC ADVANCES, 2023, 13 (27) : 18825 - 18853
12345